NEW YORK, Feb. 21 /PRNewswire-FirstCall/ -- On February 20, John Cousins, Chairman, President and CEO of Biomoda, Inc. (http://www.biomoda.com) updated the investment community in an all-new interview with www.wallst.net . Biomoda is developing early lung cancer detection testing and other cancer diagnostic technology and tools. Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, and upcoming strategic and financial milestones.
To hear the interview in its entirety, visit http://www.wallst.net , and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window.
About Biomoda:
Biomoda is a Medical Diagnostics Company developing In Vitro Diagnostic tests. These are medical tests that are run on body fluids in a clinical lab. Biomoda is developing early detection tests for cancer using our proprietary patented technology. It is based on a porphyrin molecule that has an affinity to bind with cancer and pre-cancerous cells and it fluoresces red under Ultra Violet light. This is a broad based technology that works on a wide variety of cell types. The Company's first test using this technology is for the early detection of lung cancer. It is non-invasive, simple, accurate and inexpensive; and lends itself to automated equipment so that large volumes of tests can be done and entire populations screened.
For additional information, visit the Biomoda web site at http://www.biomoda.com.
About WallSt.net:
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The web site is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications.
Biomoda, Inc.CONTACT: John Cousins, +1-505-821-0875, for Biomoda, Inc.
